Browse

Poster Abstracts

C053

A GERMLINE VARIANT IN JAK3 AS A POTENTIAL BIOMARKER OF LARYNGEAL CANCER RISK IN AFRICAN AMERICANS

Pharynx / Larynx Cancer

Jean-Nicolas Gallant, PhD1, Aliya Gifford, PhD1, Janey Wang, MS1, Rafael Guerrero, PhD2, Young Kim, MD, PhD1

1Vanderbilt University, 2University of Puerto Rico


C054

CT TEXTURE ANALYSIS WITH MACHINE LEARNING FOR THE PREDICTION OF DISEASE SITE ASSOCIATED FEATURES AND NODAL STATUS FOR HEAD AND NECK SQUAMOUS CELL CARCINOMA

Pharynx / Larynx Cancer

Xiaoyang Liu1, Eugene Yu1, Behzad Forghani2, Almudena Perez-Lara2, Shao Hui Huang1, John Waldron1, Brian O'Sullivan1, Eric Bartlett1, Mark Levental2, Thomas Ong2, Maryam Bayat2, Reza Forghani2

1University of Toronto, 2McGill University


C055

OPTIMIZED PRIMER/PROBE SETS FOR HPV-16 DETECTION IN HEAD AND NECK CARCINOMA

Pharynx / Larynx Cancer

Yuki Saito, MD, PhD1, Alexander V Favorov, PhD2, Shuling Ren, MD1, Akihiro Sakai, MD, PhD1, Takahito Fukusumi, MD, PhD1, Mizuo Ando, MD, PhD3, Chao Liu, MD1, Joseph A Califano, MD1

1Moors Cancer Center, University of California San Diego, 2Division of Oncology Biostatistics and Bioinformatics, Sidney Kimmel Comprehensive Cancer Center, Department of Oncology, Johns Hopkins University, 3Otolaryngology-Head and Neck Surgery, University of Tokyo


C056

PHARYNGEAL CONSTRICTOR BOTULINUM TOXIN INJECTION THERAPY FOR APHONIA AND DYSPHAGIA FOLLOWING TOTAL LARYNGECTOMY

Pharynx / Larynx Cancer

Shannon D Fayson, Laura Matrka, MD, Brad W deSilva, MD

The Ohio State University


C057

ONCOLOGIC OUTCOMES OF UNKNOWN PRIMARY SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK FOLLOWING TORS-BASED MANAGEMENT

Pharynx / Larynx Cancer

John R Sims, MD, Kathryn M Van Abel, MD, Katharine A Price, MD, Daniel J Ma, MD, Daniel L Price, MD, Eric J Moore, MD

Mayo Clinic


C058

ASSESSMENT OF CB1 AND CB2 RECEPTORS IN HEAD AND NECK SQUAMOUS CELL CARCINOMA

Pharynx / Larynx Cancer

Kelly E Daniels, BS, Adam J Luginbuhl, MD, Andrew P South, PhD

Thomas Jefferson University


C059

ELECTIVE PARATRACHEAL NODE AT THE TIME OF SALVAGE LARYNGECTOMY IMPROVES LOCOREGIONAL DISEASE FREE SURVIVAL AND DISEASE SPECIFIC SURVIVAL FOR RECURRENT ADVANCED GLOTTIC SQUAMOUS CELL CARCINOMA

Pharynx / Larynx Cancer

Andrew C Birkeland, MD, Andrew J Rosko, MD, Catherine T Haring, MD, Josh D Smith, J Chad Brenner, PhD, Andrew G Shuman, MD, Steven B Chinn, MD, Chaz L Stucken, MD, Kelly M Malloy, MD, Jeffrey S Moyer, MD, Keith A Casper, MD, Mark E Prince, MD, Carol R Bradford, MD, Gregory T Wolf, MD, Douglas B Chepeha, MD, Matthew E Spector, MD

University of Michigan


C060

IMPACT OF NODAL YIELD AT A SINGLE INSTITUTION IN PATIENTS UNDERGOING NECK DISSECTION AND TOTAL LARYNGECTOMY

Pharynx / Larynx Cancer

Michael C Topf, MD, Linda C Magana, PhD, James Metkus, MD, James Hamilton, MD, Larissa Sweeny, MD, William M Keane, MD, Richard A Goldman, MD, Adam Luginbuhl, MD, Joseph M Curry, MD, David M Cognetti, MD

Thomas Jefferson University Hospital


C061

SWALLOWING AND SPEECH OUTCOMES AFTER TRANSORAL ROBOTIC SURGERY +/- ADJUVANT THERAPY FOR HPV(+) OROPHARYNGEAL SQUAMOUS CELL CARCINOMA

Pharynx / Larynx Cancer

1, M H Quick1, D E Graner, CCCSLP2, C M Lohse, MS3, D J Ma, MD4, K P Price, MD5, D L Price, MD1, E J Moore, MD1

1Department of Otorhinolaryngology - Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA, 2Division of Speech Pathology, Mayo Clinic, Rochester, Minnesota, USA, 3Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA, 4Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA, 5Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA


C062

MINOR SALIVARY GLAND CARCINOMA OF THE LARYNX: A POPULATION-BASED ANALYSIS OF 311 CASES

Pharynx / Larynx Cancer

Alexander N Goel, BA, Claire Liu, BS, Iram Shafqat, BS, Jennifer L Long, MD, PhD

Department of Head and Neck Surgery, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California, USA